Unique Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNIQUE PHARM, and what generic and branded alternatives to UNIQUE PHARM drugs are available?
UNIQUE PHARM has three approved drugs.
Summary for Unique Pharm
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Unique Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unique Pharm | LORATADINE | loratadine | TABLET;ORAL | 214684-001 | Jan 7, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-003 | Apr 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Unique Pharm | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 217975-002 | Aug 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-001 | Apr 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-002 | Apr 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
